Chemicals and Drugs

Metformin Hydrochloride Drug Combination Sitagliptin Phosphate

A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

MeSH Record

Synonyms

4 entry terms
  • Sitagliptin Phosphate Metformin Hydrochloride Drug Combination
  • Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
  • Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination
  • Janumet

MeSH Record

Aspects Covered

24 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.

MeSH Record

History Note

2016 (2008)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Metformin Hydrochloride Drug Combination Sitagliptin Phosphate. Medical Subject Headings (MeSH). 2026. Unique ID D000068899. http://id.nlm.nih.gov/mesh/2026/D000068899
  2. Metformin Hydrochloride Drug Combination Sitagliptin Phosphate. In: Wikipedia. https://en.wikipedia.org/wiki/Sitagliptin/metformin
  3. Metformin Hydrochloride Drug Combination Sitagliptin Phosphate. In: Wikidata. https://www.wikidata.org/wiki/Q7531599